Home › NDC Lookup › Ingredients › Acetaminophen And Phenylephrine Hydrochl... › 42507-0320-06
⚪image loading
(from DailyMed)

Sinus Pressure and Pain PE ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE 325 mg; 5 mg Tablet, Coated

by HYVEE INC · 2 BLISTER PACK in 1 CARTON (42507-320-06) / 12 TABLET, COATED in 1 BLISTER PACK
NDC 42507-0320-06
🏷️ FDA NDC (as labeled) 42507-320-06 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 42507-320-06
Product NDC 42507-320
11-digit billing NDC 42507032006
RxCUI 1046378
UNII 362O9ITL9D, 04JA59TNSJ
Application # M012
SPL Set ID 3e60e32f-3e5f-b775-e063-6294a90a097d
Established class (EPC) alpha-1 Adrenergic Agonist
Mechanism of action Adrenergic alpha1-Agonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-10-22
Route ORAL
Dosage form TABLET, COATED
Substance ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE
Why two NDCs? The FDA registers this code as 42507-320-06 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 42507-0320-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Anilides class.

Drug family (ATC) Anilides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerHYVEE INC
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code42507
First marketedOct 2025
Product typeHuman Otc Drug
Portfolio136 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter coated tablet taken by mouth that combines acetaminophen and phenylephrine hydrochloride. Acetaminophen is typically used to reduce pain and fever, while phenylephrine hydrochloride is a nasal decongestant commonly used to relieve sinus and nasal congestion. The product is marketed as an OTC monograph drug, meaning it follows FDA's established rules for this category of sinus and pain relievers rather than being individually reviewed.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sinus Congestion and Pain Maximum Strength 325 mg/1; 5 mg 00536-1289-35 Rugby 24 tablets $0.085 — Availability likely —
Sinus Pressure Pain Maximum Strength, Non-Drowsy 325 mg/1; 5 mg 46122-0443-62 Amerisource 24 tablets $0.085 — Availability likely —
Sinus Pressure and Pain Maximum Strength 325 mg/1; 5 mg 70000-0161-01 Cardinal 24 tablets $0.085 — Availability likely —
Sinus and Headache 325 mg/1; 5 mg 70000-0568-01 Cardinal 12 tablets $0.085 — Availability likely —
Sinus plus Headache 325 mg/1; 5 mg 83324-0094-24 CHAIN 12 tablets $0.085 — Availability likely —
Panadol Cold and Flu NonDrowsy 325 mg/1; 5 mg 00135-0607-02 Haleon 8 tablets — — FDA listed —
Panadol Cold and Flu NonDrowsy 325 mg/1; 5 mg 00135-7031-01 Haleon 2 tablets — — FDA listed —
Sinus and Headache 325 mg/1; 5 mg 00363-4066-08 Walgreen 12 tablets — — FDA listed —
Sinus And Headache 325 mg/1; 5 mg 11822-4669-08 Rite 12 tablets — — FDA listed —
Sinus Pressure and Pain PE Maximum Strength 325 mg/1; 5 mg 11822-5022-08 Rite 24 tablets — — FDA listed —
Pain Relief Non Drowsy Daytime 325 mg/1; 5 mg 21130-0466-08 Better 12 tablets — — Discontinued —
Pain Relief Sinus Congestion 325 mg/1; 5 mg 21130-0474-08 Better 12 tablets — — FDA listed —
Sinus Relief MAXIMUM STRENGTH 325 mg/1; 5 mg 21130-0502-21 Better 24 tablets — — FDA listed —
Sinus Plus Headache 325 mg/1; 5 mg 30142-0466-08 Kroger 12 tablets — — FDA listed —
Sinus Pressure plus Pain PE 325 mg/1; 5 mg 36800-0320-06 TOPCO 12 tablets — — FDA listed —
Sinus plus Headache 325 mg/1; 5 mg 36800-0322-05 TOPCARE 12 tablets — — FDA listed —
Sinus Congestion and Pain Daytime Non-Drowsy 325 mg/1; 5 mg 37808-0466-08 H 12 tablets — — FDA listed —
Sinus Congestion and Pain Daytime 325 mg/1; 5 mg 41163-0664-08 United 12 tablets — — FDA listed —
Sinus and Headache 325 mg/1; 5 mg 42507-0223-05 HYVEE 12 tablets — — FDA listed —
Sinus Pressure and Pain PE 325 mg/1; 5 mgthis 42507-0320-06 HYVEE 12 tablets — — FDA listed —
Sudafed PE Sinus Pressure Plus Pain 325 mg/1; 5 mg 50580-0435-01 Kenvue 12 tablets — — FDA listed —
SUDAFED PE Pressure Plus Pain 325 mg/1; 5 mg 50580-0547-25 Kenvue 12 tablets — — FDA listed —
Tylenol Sinus Plus Headache Day 325 mg/1; 5 mg 50580-0598-01 Kenvue 12 tablets — — Discontinued —
Sinus and Headache 325 mg/1; 5 mg 50804-0123-05 GOODSENSE 12 tablets — — FDA listed —
sinus pressure and pain pe 325 mg/1; 5 mg 50804-0220-06 GOODSENSE 12 tablets — — FDA listed —
Sinus and Headache Daytime 325 mg/1; 5 mg 50844-0467-02 L.N.K. 12 tablets — — FDA listed —
Coltalin-Nd 325 mg/1; 5 mg 51467-0008-01 FORTUNE 24 tablets — — FDA listed —
Coltalin-Nd 325 mg/1; 5 mg 51467-0013-01 FORTUNE 24 tablets — — FDA listed —
Sinus Pressure plus Pain PE 325 mg/1; 5 mg 53943-0220-06 DISCOUNT 12 tablets — — FDA listed —
Sinus And Headache 325 mg/1; 5 mg 53943-0323-05 DISCOUNT 12 tablets — — FDA listed —
Sinus Headache and Pain Day, Non-drowsy 325 mg/1; 5 mg 55301-0446-08 ARMY 12 tablets — — FDA listed —
Suphedrine PE Sinus Pressure Plus Pain 325 mg/1; 5 mg 55301-0902-08 ARMY 24 tablets — — FDA listed —
Sinus and Headache 325 mg/1; 5 mg 55319-0496-08 Family 12 tablets — — FDA listed —
Sinus Pressure and Pain 325 mg/1; 5 mg 55319-0702-08 Family 24 tablets — — FDA listed —
Sinus and Headache Daytime 325 mg/1; 5 mg 55910-0466-08 DOLGENCORP, 12 tablets — — FDA listed —
Sinus Pressure and Pain Maximum Strength 325 mg/1; 5 mg 55910-0925-08 DOLGENCORP, 24 tablets — — FDA listed —
Sinus and Headache 325 mg/1; 5 mg 57344-0923-05 AAA 12 tablets — — FDA listed —
Sinus Pain And Congestion Daytime 325 mg/1; 5 mg 59779-0466-08 CVS 12 tablets — — FDA listed —
Sinus PE Pressure plus Pain MAXIMUM STRENGTH 325 mg/1; 5 mg 59779-0802-08 CVS 24 tablets — — FDA listed —
Sinus plus Headache 325 mg/1; 5 mg 63868-0582-24 CHAIN 12 tablets — — FDA listed —
Sinus Pressure plus Pain PE 325 mg/1; 5 mg 63941-0220-06 VALU 12 tablets — — FDA listed —
Nasal Decongestant PE and Pain Relief Maximum Strength 325 mg/1; 5 mg 67091-0209-24 WinCo 24 tablets — — FDA listed —
Sinus Congestion and Pain Relief Non-Drowsy 325 mg/1; 5 mg 67091-0213-24 WinCo 12 tablets — — FDA listed —
Sinus Pressure plus Pain PE 325 mg/1; 5 mg 68998-0220-06 MARC 12 tablets — — FDA listed —
Sinus plus Headache 325 mg/1; 5 mg 68998-0323-05 MARC 12 tablets — — FDA listed —
Sinus Headache PEMaximum Strength Non-Drowsy Maximum Strength Non-Drowsy 325 mg/1; 5 mg 69168-0270-95 Allegiant 18 tablets — — FDA listed —
Sinus Pressure plus Pain PE 325 mg/1; 5 mg 72036-0320-06 Harris 12 tablets — — FDA listed —
Sinus plus Headache 325 mg/1; 5 mg 72036-0323-05 Harris 12 tablets — — FDA listed —
Sinus Pressure plus Pain PE 325 mg/1; 5 mg 72476-0120-06 RETAIL 12 tablets — — FDA listed —
Sinus And Headache 325 mg/1; 5 mg 72476-0123-05 RETAIL 12 tablets — — FDA listed —
Sudafed PE Sinus Pressure Plus Pain 325 mg/1; 5 mg 85766-0183-24 Sportpharm 12 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2025
On the market since
Oct 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE — the ingredient across all brands.

Top reported reactions

Foetal Exposure During Pregnancy4
Autism Spectrum Disorder2
Blood Pressure Increased2
Headache2
Blood Urine Present1
Cardiac Arrest1
Cerebrovascular Accident1

Age at onset

Adolescent1
Adult2
Elderly1

Reporter sex

21 reports
Male · 44%
Female · 56%

Serious outcomes

Hospitalization3
Life-threatening3
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 5 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
42507-0320-06 You're viewing this 2 BLISTER PACK in 1 CARTON (42507-320-06) / 12 TABLET, COATED in 1 BLISTER PACK 2025-10-22 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 42507-320-06, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 42507-0320-06, written without dashes as 42507032006. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 42507-0320-06, the first segment (42507) is the labeler code FDA assigned to HYVEE INC; the middle segment (0320) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (06) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by HYVEE INC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
HYVEE INC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 35 words ▾

Uses temporarily relieves these symptoms associated with hay fever or other upper respiratory allergies, and the common cold: sinus congestion and pressure headache minor aches and pains nasal congestion promotes sinus drainage temporarily reduces fever

⏱️ Dosage and Administration 41 words ▾

Directions do not take more than directed (see overdose warning ) adults and children 12 years and over take 2 caplets every 4 hours do not take more than 10 caplets in 24 hours children under 12 years ask a doctor

⚠️ Warnings ~2 min read ▾

Warnings Liver warning This product contains acetaminophen. The maximum daily dose of this product is 10 caplets (3,250 mg acetaminophen) in 24 hours. Severe liver damage may occur if you take more than 4,000 mg of acetaminophen in 24 hours with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Allergy alert Acetaminophen may cause severe skin reactions.

Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away. Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.

If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. if you have ever had an allergic reaction to this product or any of its ingredients Ask a doctor before use if you have liver disease heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin When using this product do not exceed recommended dosage Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur pain or nasal congestion gets worse or lasts more than 7 days fever gets worse or lasts more than 3 days redness or swelling is present new symptoms occur These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. Overdose warning In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

📦 Storage and Handling 18 words ▾

Other information store between 20-25ºC (68-77ºF) in a dry place retain carton for complete product information and warnings

🧪 Active Ingredient 18 words ▾

Active ingredients (in each caplet) Purpose Acetaminophen 325 mg Pain reliever/fever reducer Phenylephrine HCl 5 mg Nasal decongestant

🧪 Inactive Ingredients 34 words ▾

Inactive ingredients colloidal silicon dioxide, corn starch, croscarmellose sodium, crospovidone, FD&C yellow #6 aluminum lake, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, pregelatinized starch, stearic acid, talc, titanium dioxide

🎯 Purpose 18 words ▾

Active ingredients (in each caplet) Purpose Acetaminophen 325 mg Pain reliever/fever reducer Phenylephrine HCl 5 mg Nasal decongestant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 42507-0319-64 · HyVee 42507-0321-50 · HyVee →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.